Extension of the Systematic Toxicological Screening Library for use with the Waters Nominal Mass Screening Solutions

Importance of the Topic

Forensic and clinical laboratories require robust, high-throughput screening methods to detect an ever-expanding roster of drugs, metabolites, and novel psychoactive substances (NPS) in complex biological samples. Comprehensive toxicological screening libraries enable reliable identification of target compounds in postmortem, clinical, and sports doping investigations, ensuring timely and accurate results.

Objectives and Study Overview

This work aimed to extend the existing Waters nominal mass Systematic Toxicological Analysis (STA) library by adding 244 toxicologically relevant analytes. The goal was to raise the total screening coverage from approximately 950 to 1,200 compounds, enhancing detection of designer benzodiazepines, psychedelic tryptamines, fentanyl analogs, as well as sports doping agents such as beta blockers, diuretics, steroids, and receptor modulators.

Methodology and Instrumentation

Standard preparations of single and mixed analytes (2,500 ng/mL) were made in 5 mM ammonium formate (pH 3). Full-scan electrospray data were acquired on a Waters ACQUITY UPLC I-Class coupled to a Xevo TQD mass spectrometer using the STA acquisition method. Multiple cone voltages (20–95 V) generated in-source fragmentation patterns. Data processing and library creation were performed with the ChromaLynx Application Manager, exporting a NIST-compatible library. The resulting library was then converted for use on the Xevo TQ-S micro system without altering spectral content.

Main Results and Discussion

The expanded library now contains 1,200 analytes with retention times, molecular formulas, and multi-voltage spectra. Key additions include designer benzodiazepines, novel tryptamines, and emerging fentanyl analogs. Representative fragmentation data for 5-MeO-DMT illustrate stable spectral profiles across cone voltages. Compatibility with both Xevo TQD and Xevo TQ-S micro instruments ensures flexible deployment in diverse laboratory environments.

Benefits and Practical Applications

• Broadens screening scope for routine forensic and clinical toxicology.
• Supports rapid 15-minute full-scan workflows for high throughput.
• Facilitates sports doping analysis with added performance-enhancing and masking agents.
• Simplifies custom library creation using ChromaLynx tools for local standards or authentic samples.

Future Trends and Opportunities

As the drug landscape evolves, further extension of libraries will be essential. Integration of high-resolution mass spectrometry, machine learning-driven spectral matching, and real-time updates for emerging NPS are promising directions. Cross-platform compatibility and cloud-based library sharing can accelerate adoption and collaborative development.

Conclusion

The new STA library extension substantially increases analytical coverage, enabling detection of 1,200 drugs and metabolites on Waters nominal mass screening platforms. Easy integration and broad instrument support empower laboratories to keep pace with dynamic toxicological challenges.

References

1. Humbert L, Lhermitte M, Grisel F. General Unknown Screening for Drugs in Biological Samples by LC/MS. Waters Application Note 720001552EN, 2007.
2. Lee R, Roberts M, Paccou A, Wood M. Development of a New UPLC/MS Method for Systematic Toxicological Analysis. Waters Application Note 720002905EN, 2009.
3. Humbert L et al. Screening of Xenobiotics by UPLC–MS Using In-Source Fragmentation at Increasing Cone Voltages: Library Constitution and an Evaluation of Spectral Stability. J Anal Toxicol. 34:571–580, 2010.
4. Rosano T, Wood M, Swift T. Postmortem Drug Screening by Non-Targeted and Targeted UPLC-MS Technology. J Anal Toxicol. 35:411–423, 2011.
5. Roberts M, Wood M. Forensic Toxicology Screening Using the ACQUITY UPLC I-Class System with the Xevo TQD. Waters Application Note 720004602EN, 2013.
6. Lee R, Wood M. Systematic Toxicological Screening Using the ACQUITY I-Class/Xevo TQ-S micro. Waters Application Note 720005661EN, 2016.